hrp0084p3-857 | Fat | ESPE2015
Moayeri Heshmat
Background: Treatment with the gonadotropin releasing hormone (GnRH) agonist is the treatment of choice for central precocious puberty (CPP).Objective and hypotheses: Concept have been expressed that GNRH treatment may be associated with increased BMI and it is controversial in some studies.Method: We studied the height, weight, and BMI of 52 girls that the majority of them had CPP. All patients were treated with GNRH analog...